Media stories about Allied Healthcare Products (NASDAQ:AHPI) have been trending somewhat positive on Monday, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Allied Healthcare Products earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 0 out of 100, indicating that recent press coverage is extremely unlikely to have an impact on the stock’s share price in the next several days.

Allied Healthcare Products (NASDAQ AHPI) traded up 0.93% during midday trading on Monday, hitting $2.18. The stock had a trading volume of 4,793 shares. The company’s market cap is $8.75 million. The company has a 50-day moving average price of $2.46 and a 200-day moving average price of $2.10. Allied Healthcare Products has a 12-month low of $1.04 and a 12-month high of $3.82.

Allied Healthcare Products (NASDAQ:AHPI) last issued its quarterly earnings results on Monday, May 15th. The medical equipment provider reported ($0.10) earnings per share for the quarter. Allied Healthcare Products had a negative net margin of 5.35% and a negative return on equity of 10.80%. The firm had revenue of $8.58 million during the quarter.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at

Allied Healthcare Products Company Profile

Allied Healthcare Products, Inc manufactures a range of respiratory products used in the healthcare industry in a range of hospital and alternate site settings, including sub-acute care facilities, home healthcare and emergency medical care. The Company’s respiratory care products are used in the treatment of acute and chronic respiratory disorders such as asthma, emphysema, bronchitis and pneumonia.

Receive News & Stock Ratings for Allied Healthcare Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products Inc. and related stocks with our FREE daily email newsletter.